Cargando…

Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study

Helicobacter pylori (H. pylori), an established risk factor for gastric cancer, is suggested to also play a role in the development of pancreatic cancer; however, the association remains inconclusive. We examined this association among Japanese men and women. H. pylori and atrophic gastritis (AG) st...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirabayashi, Mayo, Inoue, Manami, Sawada, Norie, Saito, Eiko, Abe, Sarah K., Hidaka, Akihisa, Iwasaki, Motoki, Yamaji, Taiki, Shimazu, Taichi, Tsugane, Shoichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465350/
https://www.ncbi.nlm.nih.gov/pubmed/30988344
http://dx.doi.org/10.1038/s41598-019-42365-w
_version_ 1783410927168651264
author Hirabayashi, Mayo
Inoue, Manami
Sawada, Norie
Saito, Eiko
Abe, Sarah K.
Hidaka, Akihisa
Iwasaki, Motoki
Yamaji, Taiki
Shimazu, Taichi
Tsugane, Shoichiro
author_facet Hirabayashi, Mayo
Inoue, Manami
Sawada, Norie
Saito, Eiko
Abe, Sarah K.
Hidaka, Akihisa
Iwasaki, Motoki
Yamaji, Taiki
Shimazu, Taichi
Tsugane, Shoichiro
author_sort Hirabayashi, Mayo
collection PubMed
description Helicobacter pylori (H. pylori), an established risk factor for gastric cancer, is suggested to also play a role in the development of pancreatic cancer; however, the association remains inconclusive. We examined this association among Japanese men and women. H. pylori and atrophic gastritis (AG) status were determined serologically, using blood sample collected during health checkups. A total of 20,116 subjects enrolled in the Japan Public Health Center-based Prospective Study Cohort II with available data on H. pylori seropositivity (anti-H. pylori) and AG were followed until the end of 2010. Cox proportional hazards models were used to calculate the hazard ratios (HR) and 95% confidence intervals (CI), using the information from the baseline survey. During 320,470 person-years of follow-up, 119 cases of pancreatic cancer were identified. No statically significant increase or decrease in pancreatic cancer risk was observed for H. pylori and AG status, independently or in combination. In a multivariable-adjusted model, we observed a non-significant decrease in the risk among those who had AG but were anti-H. pylori seronegative (HR 0.57, 95% CI 0.31–1.03). In a stratified analysis, we observed a statistically significant increased risk of pancreatic cancer for AG+ (HR 3.64, 95% CI 1.37–9.66), and AG+/anti-H. pylori− or AG+/anti-H. pylori+ (HR 5.21, 95% CI 1.14–23.87) among current smokers. Non-smokers in all categories of AG and anti-H. pylori showed a non-statistical decrease in the risk. There was no statistically significant interaction between H. pylori infection, AG status, and smoking status. Our findings suggest H. pylori seropositivity and AG, individually or in combination, are not associated with the risk of pancreatic cancer in a general Japanese population. Among current smokers, pancreatic cancer risk increased with AG, regardless of H. pylori infection status.
format Online
Article
Text
id pubmed-6465350
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64653502019-04-18 Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study Hirabayashi, Mayo Inoue, Manami Sawada, Norie Saito, Eiko Abe, Sarah K. Hidaka, Akihisa Iwasaki, Motoki Yamaji, Taiki Shimazu, Taichi Tsugane, Shoichiro Sci Rep Article Helicobacter pylori (H. pylori), an established risk factor for gastric cancer, is suggested to also play a role in the development of pancreatic cancer; however, the association remains inconclusive. We examined this association among Japanese men and women. H. pylori and atrophic gastritis (AG) status were determined serologically, using blood sample collected during health checkups. A total of 20,116 subjects enrolled in the Japan Public Health Center-based Prospective Study Cohort II with available data on H. pylori seropositivity (anti-H. pylori) and AG were followed until the end of 2010. Cox proportional hazards models were used to calculate the hazard ratios (HR) and 95% confidence intervals (CI), using the information from the baseline survey. During 320,470 person-years of follow-up, 119 cases of pancreatic cancer were identified. No statically significant increase or decrease in pancreatic cancer risk was observed for H. pylori and AG status, independently or in combination. In a multivariable-adjusted model, we observed a non-significant decrease in the risk among those who had AG but were anti-H. pylori seronegative (HR 0.57, 95% CI 0.31–1.03). In a stratified analysis, we observed a statistically significant increased risk of pancreatic cancer for AG+ (HR 3.64, 95% CI 1.37–9.66), and AG+/anti-H. pylori− or AG+/anti-H. pylori+ (HR 5.21, 95% CI 1.14–23.87) among current smokers. Non-smokers in all categories of AG and anti-H. pylori showed a non-statistical decrease in the risk. There was no statistically significant interaction between H. pylori infection, AG status, and smoking status. Our findings suggest H. pylori seropositivity and AG, individually or in combination, are not associated with the risk of pancreatic cancer in a general Japanese population. Among current smokers, pancreatic cancer risk increased with AG, regardless of H. pylori infection status. Nature Publishing Group UK 2019-04-15 /pmc/articles/PMC6465350/ /pubmed/30988344 http://dx.doi.org/10.1038/s41598-019-42365-w Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Hirabayashi, Mayo
Inoue, Manami
Sawada, Norie
Saito, Eiko
Abe, Sarah K.
Hidaka, Akihisa
Iwasaki, Motoki
Yamaji, Taiki
Shimazu, Taichi
Tsugane, Shoichiro
Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study
title Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study
title_full Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study
title_fullStr Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study
title_full_unstemmed Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study
title_short Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study
title_sort helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: a population-based cohort study in a large japanese population: the jphc study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465350/
https://www.ncbi.nlm.nih.gov/pubmed/30988344
http://dx.doi.org/10.1038/s41598-019-42365-w
work_keys_str_mv AT hirabayashimayo helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT inouemanami helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT sawadanorie helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT saitoeiko helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT abesarahk helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT hidakaakihisa helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT iwasakimotoki helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT yamajitaiki helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT shimazutaichi helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy
AT tsuganeshoichiro helicobacterpyloriinfectionatrophicgastritisandriskofpancreaticcancerapopulationbasedcohortstudyinalargejapanesepopulationthejphcstudy